Search

everythinglearnresearchcommunity

for

Search:↓

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Both induced and spontaneous AA lymphocytes can cause alopecia areata in mice.

Steven Kossard classified lymphocyte-related hair loss into four patterns, each linked to different types of baldness.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

Lymphocytic mural folliculitis in cats might be an early sign of pancreatic cancer.

Keloid skin disorder involves abnormal fibroblast activation and immune response, linked to a group of genes including FGF11.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Minoxidil doesn't affect perifollicular lymphoid infiltration in alopecia areata patients.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

A new skin disease in four Labrador retrievers responded well to immunosuppressive treatment.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

Fetal skin has unique immune cells different from adult skin.

Higher MPV and CRP levels may indicate more severe alopecia areata.

ICL is a condition with low CD4+ T cells like AIDS but not caused by HIV, and normal CD4+ T cell counts may vary between men and women.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Simvastatin helps hair regrowth in autoimmune alopecia by directly affecting T cells.

Folliculotropic mycosis fungoides can occur in children and is diagnosed with specific tests, but often stays in early stages with treatment.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

UVA1-light therapy successfully treated a child's skin condition, mycosis fungoides.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

Alopecia Areata might be linked to Crohn's disease.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

Tufted folliculitis is common in patients with folliculitis decalvans.

Certain microRNAs may protect against hair loss in alopecia areata and could be potential treatment targets.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.